Get the Stockscreener App
0.5793
6.56%
-0.0407
After Hours:
.59
0.0107
+1.85%
Plus Therapeutics Inc stock is traded at $0.5793, with a volume of 9.99M.
It is down -6.56% in the last 24 hours and up +39.39% over the past month.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
See More
Previous Close:
$0.62
Open:
$0.61615
24h Volume:
9.99M
Relative Volume:
0.46
Market Cap:
$57.50M
Revenue:
-
Net Income/Loss:
$-12.89M
P/E Ratio:
-0.229
EPS:
-2.53
Net Cash Flow:
$-11.95M
1W Performance:
-14.44%
1M Performance:
+39.39%
6M Performance:
-12.04%
1Y Performance:
-59.77%
1-Day Range:
$0.5634
$0.6473
1-Week Range:
$0.5634
$0.733
52-Week Range:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Name
Plus Therapeutics Inc
Sector
Industry
Phone
737.255.7194
Address
4200 MARATHON BLVD., AUSTIN, TX
Compare PSTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.5793 | 61.54M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.10 | 106.87B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
491.22 | 63.14B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.77 | 61.27B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
849.46 | 51.94B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
167.91 | 35.04B | 398.11M | -1.03B | -868.57M | -5.7032 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Mar-17-25 | Initiated | D. Boral Capital | Buy |
| Jan-25-21 | Initiated | Ladenburg Thalmann | Buy |
| Oct-16-20 | Initiated | Maxim Group | Buy |
Plus Therapeutics Inc Stock (PSTV) Latest News
Combining price and volume data for Plus Therapeutics Inc.Quarterly Portfolio Report & Proven Capital Preservation Methods - newser.com
Is Plus Therapeutics Inc. (XMP0) stock protected from inflation2025 Pullback Review & Free Verified High Yield Trade Plans - newser.com
Should you hold or exit Plus Therapeutics Inc. now2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-21 08:07:06 - nchmf.gov.vn
Applying Elliott Wave Theory to Plus Therapeutics Inc.July 2025 Institutional & Technical Buy Zone Confirmation - newser.com
Published on: 2025-10-20 19:48:31 - newser.com
Why Plus Therapeutics Inc. stock could outperform in 2025Weekly Stock Report & Fast Moving Stock Watchlists - newser.com
Analysis Recap: Can Plus Therapeutics Inc. (XMP0) stock stage a strong rebound this quarterMarket Trend Review & Weekly Watchlist for Consistent Profits - nchmf.gov.vn
Published on: 2025-10-20 23:29:07 - nchmf.gov.vn
How Plus Therapeutics Inc. (XMP0) stock moves on employment dataEarnings Growth Summary & Safe Entry Trade Signal Reports - newser.com
Candlestick signals on Plus Therapeutics Inc. stock today2025 Technical Overview & Growth Focused Stock Reports - newser.com
Using Ichimoku Cloud for Plus Therapeutics Inc. technicalsJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com
Identifying reversal signals in Plus Therapeutics Inc.Trade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Plus Therapeutics Inc. stock entering bullish territoryJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Why Plus Therapeutics Inc. stock remains on watchlists2025 Sector Review & AI Powered Market Entry Ideas - newser.com
Plus Therapeutics Inc. stock outlook for YEAREarnings Trend Report & Daily Growth Stock Tips - newser.com
Combining machine learning predictions for Plus Therapeutics Inc.Weekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Real time scanner hits for Plus Therapeutics Inc. explainedTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
PLUS THERAPEUTICS, Inc. (PSTV) Stock forecasts - Yahoo
Order flow analysis tools used on Plus Therapeutics Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
Will Plus Therapeutics Inc. stock benefit from infrastructure spendingForecast Cut & Weekly Chart Analysis and Trade Guides - Trung tâm Dự báo KTTV quốc gia
Will Plus Therapeutics Inc. stock see insider buyingChart Signals & Verified Swing Trading Watchlists - nchmf.gov.vn
Can Plus Therapeutics Inc. stock beat market expectations this quarter2025 Earnings Impact & Risk Adjusted Buy and Sell Alerts - Trung tâm Dự báo KTTV quốc gia
What MACD and RSI say about Plus Therapeutics Inc.2025 Key Lessons & Technical Pattern Based Signals - newser.com
Top chart patterns to watch in Plus Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - newser.com
Why Plus Therapeutics Inc. is moving todayTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
What momentum shifts mean for Plus Therapeutics Inc.July 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge - MarketScreener
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance
Multi factor analysis applied to Plus Therapeutics Inc.2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - The Globe and Mail
Plus Therapeutics Inc Stock (PSTV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
2.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):